AMETEK (NYSE:AME) Posts Earnings Results, Beats Expectations By $0.07 EPS

AMETEK (NYSE:AME) released its quarterly earnings results on Tuesday. The technology company reported $2.01 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.07, Briefing.com reports. AMETEK had a net margin of 20.50% and a return on equity of 16.66%. The business’s revenue for the quarter was up 13.4% compared to the same quarter last year. During the same period last year, the firm earned $1.87 EPS. AMETEK updated its Q1 2026 guidance to 1.850-1.900 EPS and its FY 2026 guidance to 7.870-8.070 EPS.

AMETEK Trading Up 2.0%

Shares of NYSE AME opened at $228.48 on Tuesday. AMETEK has a fifty-two week low of $145.02 and a fifty-two week high of $229.03. The firm has a market capitalization of $52.60 billion, a P/E ratio of 36.04, a P/E/G ratio of 3.05 and a beta of 1.03. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.16 and a quick ratio of 0.72. The company’s 50 day simple moving average is $208.39 and its 200 day simple moving average is $194.48.

AMETEK Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Friday, December 5th were issued a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 0.5%. The ex-dividend date was Friday, December 5th. AMETEK’s dividend payout ratio is currently 19.56%.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AME. TD Cowen raised AMETEK from a “sell” rating to a “buy” rating in a report on Tuesday, December 23rd. Royal Bank Of Canada lifted their price target on AMETEK from $212.00 to $229.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Wall Street Zen raised shares of AMETEK from a “hold” rating to a “buy” rating in a report on Saturday, November 1st. Morgan Stanley boosted their target price on shares of AMETEK from $198.00 to $215.00 and gave the stock an “equal weight” rating in a research note on Monday, January 12th. Finally, KeyCorp increased their price target on shares of AMETEK from $220.00 to $235.00 and gave the company an “overweight” rating in a research note on Tuesday, January 6th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, AMETEK presently has an average rating of “Moderate Buy” and a consensus target price of $229.82.

Insider Buying and Selling at AMETEK

In other news, CEO David A. Zapico sold 28,390 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $201.76, for a total value of $5,727,966.40. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Thomas M. Montgomery sold 6,388 shares of the firm’s stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $205.05, for a total value of $1,309,859.40. Following the completion of the transaction, the vice president owned 22,116 shares in the company, valued at $4,534,885.80. This represents a 22.41% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 137,088 shares of company stock worth $27,212,340. Insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On AMETEK

Several institutional investors have recently modified their holdings of the stock. State Street Corp raised its position in shares of AMETEK by 1.3% in the 3rd quarter. State Street Corp now owns 9,763,684 shares of the technology company’s stock valued at $1,835,573,000 after acquiring an additional 126,381 shares during the period. Invesco Ltd. increased its stake in AMETEK by 4.9% in the third quarter. Invesco Ltd. now owns 4,463,518 shares of the technology company’s stock valued at $839,141,000 after purchasing an additional 209,043 shares in the last quarter. Lazard Asset Management LLC raised its holdings in AMETEK by 35.7% in the third quarter. Lazard Asset Management LLC now owns 2,645,977 shares of the technology company’s stock worth $497,444,000 after purchasing an additional 695,419 shares during the period. Northern Trust Corp boosted its position in shares of AMETEK by 0.4% during the third quarter. Northern Trust Corp now owns 2,436,237 shares of the technology company’s stock worth $458,013,000 after purchasing an additional 10,510 shares in the last quarter. Finally, AQR Capital Management LLC grew its holdings in shares of AMETEK by 37.8% in the 3rd quarter. AQR Capital Management LLC now owns 904,034 shares of the technology company’s stock valued at $169,588,000 after buying an additional 247,922 shares during the period. 87.43% of the stock is currently owned by institutional investors and hedge funds.

AMETEK News Summary

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Reported record fourth‑quarter and full‑year 2025 results, reinforcing underlying business strength. AMETEK Announces Record Fourth Quarter and Full Year Results
• Positive Sentiment: Completed acquisition of LKC Technologies (adds ophthalmic diagnostic capabilities), expanding AMETEK’s medical/diagnostics exposure and product portfolio. AMETEK Acquires LKC Technologies DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK
• Neutral Sentiment: Pre‑earnings coverage and previews highlight improving process markets and set context for investor expectations ahead of management commentary. Ametek Earnings on Deck as Process Markets Show Signs of Life Ametek Q4 2025 Earnings Preview
• Negative Sentiment: Updated FY‑2026 EPS guidance of $7.87–$8.07 is slightly below the consensus of $8.00, signaling more modest full‑year growth than investors expected.
• Negative Sentiment: Q1‑2026 EPS guidance of $1.85–$1.90 is at/just below the $1.90 consensus; revenue guidance centered around ~$1.9B also met modest expectations — collectively this conservative near‑term outlook is pressuring the stock.
• Negative Sentiment: Giverny Capital trimmed its AMETEK position, citing valuation, which is a small negative signal about investor positioning. Giverny Capital Asset Management Trimmed Ametek (AME) on Valuation

AMETEK Company Profile

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.